Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Daichi, Nagai"'
Autor:
Daichi Nagai, Taku Shoji, Miwa Tanaka, Takanori Araki, Tetsuo Okujima, Shunji Ito, Akira Ohta, Shigeki Mori, Ryuta Sekiguchi
Publikováno v:
Chemistry - A European Journal. 23:5126-5136
Synthesis of 2-aminofuran derivatives with an azulene or N,N-dimethylanilino substituent was established by the formal [2+2] cycloaddition-retroelectrocyclization of 3-(1-azulenyl or N,N-dimethylanilino)-2-propyn-1-ols with tetracyanoethylene, follow
Autor:
Takeshi Onda, Hitomi Hayashi, Hiroko Mashiba, Iwao Nakamura, Akira Masuda, Daichi Nagai, Eiji Ichimura, Hirofumi Yokoyama, Rika Goda
Publikováno v:
International Journal of Nanomedicine
Iwao Nakamura, Eiji Ichimura, Rika Goda, Hitomi Hayashi, Hiroko Mashiba, Daichi Nagai, Hirofumi Yokoyama, Takeshi Onda, Akira Masuda Nanomedicine Group, Pharmaceutical Research Laboratories, Nippon Kayaku Co., Ltd., Tokyo, Japan Abstract: In our prev
Autor:
Miwa Tanaka, Ryuta Sekiguchi, Akifumi Maruyama, Taku Shoji, Daichi Nagai, Tetsuo Okujima, Shunji Ito, Mitsuhisa Maruyama
Publikováno v:
HETEROCYCLES. 95(1):353-369
Azulene-substituted tetracyanobutadienes (AzTCBDs) and dicyanoquinodimethanes (AzDCNQs) connected with naphthalene cores were prepared by the reaction of 1-azulenylalkynes with tetracyanoethylene (TCNE) and 7,7,8,8-tetracyanoquinodimethane (TCNQ) in
Autor:
Taku Shoji, Masafumi Yasunami, Daichi Nagai, Kunihide Fujimori, Tetsuo Okujima, Miwa Tanaka, Shunji Ito, Kozo Toyota, Erika Shimomura, Akifumi Maruyama
Publikováno v:
ChemistrySelect. 1:49-57
Tris[(3-phenyl-1-azulenyl)tetracyanobutadiene]s and tris(aryltetracyanobutadiene)s connected to a 1,3,5-tri(1-azulenyl)benzene core (tris-AzTCBDs) have been prepared by the Pd-catalyzed alkynylation of tris(3-iodo-1-azulenyl)benzene derivative with t
Autor:
Makiko Motoi-Ohtsuji, Hisakazu Iwai, Kunihiro Ohta, Jun Katagi, Tadayoshi Ueda, Motoharu Kakiki, Takuo Ogihara, Takuya Nagao, Sho Tanaka, Kumiko Kusumoto, Norihito Matsumoto, Daichi Nagai, Hiroshi Arakawa, Takako Ohkura, Shinya Kaneda, Emiko Ozeki, Tomoko Jomura, Yukiko Inoue
Publikováno v:
Fundamental Toxicological Sciences. 2:41-48
Autor:
Daichi Nagai, Osamu Miyazaki, Kazuya Okamoto, Eiji Ichimura, Yoshitaka Miyakawa, Tomio Morino, Keiko Ebara, Takeshi Onda, Keiko Sekine, Naoko Nakajima
Publikováno v:
International Journal of Cancer. 134:218-223
NK012 is a micelle-forming macromolecular prodrug of 7-ethyl-10-hydroxy camptothecin (SN-38), an active metabolite of irinotecan. It is accumulated and retained in tumor tissues and gradually releases SN-38 in an enzyme-independent manner. NK012 was
Autor:
Yasushi Matsuzaki, Mikio Doi, Eiji Ichimura, Kiyohiro Nishikawa, Arihiro Tomura, Daichi Nagai, Rika Goda
Publikováno v:
Journal of Gastroenterology. 41:231-239
Flutamide, a nonsteroidal antiandrogen used for treatment of prostate cancer, causes a temporary increase in transaminase and in some cases severe liver dysfunction. It is dominantly metabolized by cytochrome P450 (CYP) 1A2 into 2-hydroxyflutamide (O
Autor:
Osamu, Miyazaki, Keiko, Sekine, Naoko, Nakajima, Eiji, Ichimura, Keiko, Ebara, Daichi, Nagai, Takeshi, Onda, Yoshitaka, Miyakawa, Kazuya, Okamoto, Tomio, Morino
Publikováno v:
International journal of cancer. 134(1)
NK012 is a micelle-forming macromolecular prodrug of 7-ethyl-10-hydroxy camptothecin (SN-38), an active metabolite of irinotecan. It is accumulated and retained in tumor tissues and gradually releases SN-38 in an enzyme-independent manner. NK012 was
Autor:
Hiroko Mashiba, Hitomi Hayashi, Daichi Nagai, Norio Wake, Hiroaki Kobayashi, Eiji Ichimura, Kiyohiro Nishikawa, Iwao Nakamura, Kazuya Okamoto, Keiko Ebara
Publikováno v:
Arzneimittel-Forschung. 60(4)
Paclitaxel Inj. [NK] (test; paclitaxel, CAS 33069-62-4) is a generic version of the drug from the originator (reference). Both drugs contain the same active ingredient and showed identical pharmacokinetics in patients in the previous study; however,
Autor:
Yasushi Yamazoe, Daichi Nagai, Kouichi Yoshinari, Miki Shimada, Masato Ohbuchi, Masaaki Miyata
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 37(1)
Flutamide is used for prostate cancer therapy but occasionally induces severe liver injury. Flutamide is hydrolyzed in the body into 5-amino-2-nitrobenzotrifluoride (FLU-1) and then further oxidized. In our previous study, N-hydroxy FLU-1 (FLU-1 N-OH